Century Therapeutics Stock Pattern Recognition Matching Low
| IPSC Stock | USD 1.90 0.11 5.47% |
| Symbol |
Recognition |
The output start index for this execution was six with a total number of output elements of fifty-five. The function generated a total of one valid pattern recognition events for the selected time horizon. The Matching Low pattern shows low bullish reversal trend for Century Therapeutics.
Century Therapeutics Technical Analysis Modules
Most technical analysis of Century Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Century from various momentum indicators to cycle indicators. When you analyze Century charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Century Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Century Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Century Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Century Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Century Therapeutics's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Century Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Century Therapeutics, we also check how macroeconomic factors affect Century Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.82 | 0.68 | 0.62 | 0.52 | Revenue Per Share | 0.0377 | 0.0838 | 0.0963 | 0.0775 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Century Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Century Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Century Stock refer to our How to Trade Century Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Biotechnology sector continue expanding? Could Century diversify its offerings? Factors like these will boost the valuation of Century Therapeutics. Market participants price Century higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Century Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.32) | Revenue Per Share | Quarterly Revenue Growth 126.677 | Return On Assets | Return On Equity |
Investors evaluate Century Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Century Therapeutics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Century Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Century Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Century Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Century Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.